Cairn Investment Group Inc. Has $2.35 Million Stock Holdings in Cardinal Health, Inc. $CAH

Key Points

• Cairn Investment Group boosted its stake in Cardinal Health by 526.7% in Q4 and now owns 11,437 shares valued at about $2.35 million.
• Cardinal Health posted a Q3 EPS beat ($3.17 vs. $2.79 est.), raised FY‑2026 guidance to $10.70–$10.80 and executed an additional $250M buyback, but revenue missed expectations and GAAP results were hit by a $184M goodwill impairment, producing a mixed outlook.
• Wall Street sentiment is broadly positive (average rating "Moderate Buy") with a consensus price target around $243.67, while the stock recently traded up about 1.2% and carries a market cap near $46 billion.

Cairn Investment Group Inc. lifted its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 526.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,437 shares of the company's stock after purchasing an additional 9,612 shares during the period. Cairn Investment Group Inc.'s holdings in Cardinal Health were worth $2,350,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. SJS Investment Consulting Inc. grew its stake in Cardinal Health by 1,363.6% in the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company's stock valued at $25,000 after buying an additional 150 shares during the last quarter. Aventura Private Wealth LLC acquired a new position in Cardinal Health in the 4th quarter valued at about $25,000. Jones Financial Companies Lllp grew its stake in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after buying an additional 14,034 shares during the last quarter. JPL Wealth Management LLC acquired a new position in Cardinal Health in the 3rd quarter valued at about $31,000. Finally, Turning Point Benefit Group Inc. acquired a new position in Cardinal Health in the 3rd quarter valued at about $31,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Q3 non‑GAAP earnings beat estimates and company raised FY‑2026 guidance to $10.70–$10.80, above consensus — the core bullish catalyst. PR Newswire: Q3 Results & Outlook
• Positive Sentiment: Company executed $250M additional share repurchase (bringing FY26 repurchases to $1.0B) and reduced debt — shareholder‑friendly actions that support the share price. PR Newswire: Buybacks & Debt Reduction
• Neutral Sentiment: Wells Fargo cut its price target from $256 to $245 but kept an "overweight" rating, signaling continued analyst confidence despite the trim. Benzinga: Wells Fargo PT Change
• Neutral Sentiment: Full earnings call and transcripts are available for investors who want details on segment performance and management commentary. Yahoo Finance: Earnings Transcript Seeking Alpha: Call Transcript
• Negative Sentiment: Revenue missed expectations ($60.9B reported vs. ~$62.1B est.), which prompted media coverage and short‑term selling pressure despite the EPS beat. Benzinga: Revenue Miss Coverage
• Negative Sentiment: GAAP results were weaker: GAAP operating earnings and GAAP EPS declined, driven in part by a $184M pre‑tax goodwill impairment in the Navista & ION reporting unit — a one‑time charge that reduces headline profitability. PR Newswire: Goodwill Impairment
• Negative Sentiment: Several outlets highlighted the "mixed" nature of the report (EPS/guidance vs. revenue/GAAP weakness), which can increase volatility and keep some investors on the sidelines. CNBC: Mixed Results Coverage

Cardinal Health Stock Up 1.2%

NYSE CAH opened at $195.13 on Friday. The company has a market capitalization of $45.92 billion, a P/E ratio of 29.84, a P/E/G ratio of 1.20 and a beta of 0.53. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60. The firm has a 50-day moving average price of $213.73 and a two-hundred day moving average price of $205.82.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business's revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities analysts expect that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st were issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend was Wednesday, April 1st. Cardinal Health's dividend payout ratio is 29.35%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on CAH shares. UBS Group set a $260.00 price target on shares of Cardinal Health and gave the company a "buy" rating in a research note on Friday, February 6th. Robert W. Baird set a $248.00 price target on shares of Cardinal Health in a research note on Friday. Mizuho upped their price target on shares of Cardinal Health from $222.00 to $235.00 and gave the company an "outperform" rating in a research note on Friday, February 6th. JPMorgan Chase & Co. upped their price target on shares of Cardinal Health from $209.00 to $243.00 and gave the company a "neutral" rating in a research note on Tuesday, February 10th. Finally, Leerink Partners reiterated an "outperform" rating and issued a $275.00 price target on shares of Cardinal Health in a research note on Monday, March 9th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Cardinal Health currently has an average rating of "Moderate Buy" and a consensus price target of $243.67.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.